Skip to main content
Erschienen in: Psychiatric Quarterly 2/2015

01.06.2015 | Original Paper

The 12 Item W.H.O.D.A.S. as Primary Self Report Outcome Measure in a Correctional Community Treatment Center for Dually Diagnosed Patients

verfasst von: Leo Bastiaens, James Galus, Michael Goodlin

Erschienen in: Psychiatric Quarterly | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The World Health Organization Disability Assessment Scale (WHODAS) is suggested as a measure of impairment in DSM-5. The measurement of impaired functioning is crucial in the rehabilitation of dually diagnosed, addiction and mental health, patients. This study is the first to look at the use of the 12 item self report WHODAS as the primary outcome in a community correctional treatment facility for dually diagnosed patients.100 (55 male; 73 white, 25 black, 2 hispanic) former inmates, age 36.1 ± 11.1, with psychiatric and addiction diagnoses were treated in an integrated program. The 12 item WHODAS was completed by the patients during the initial evaluation and repeated an average of 11.1 ± 2.7 weeks later. The Clinical Global Impression-Severity Scale (CGI) was completed at the same time by the psychiatrist, independently of the WHODAS. At initial assessment, the CGI showed moderate severity and the WHODAS showed severe disability. CGI and WHODAS were significantly correlated (R 0.48, p < 0.0001). After three months of treatment, both measures improved: CGI with 46 % and WHODAS with 49 %. The CGI showed mild severity and the WHODAS moderate disability. The change in CGI was correlated with the change in WHODAS (R 0.57, p < 0.0001). The WHODAS appears sensitive to clinical improvement related to shortterm treatment of a highly co-morbid dual diagnosis population.
Literatur
2.
Zurück zum Zitat Schnittker J, Massoglia, M, Uggen C. Out and down: Incarceration and psychiatric disorder. J Health Social Beh. 2012; 53: 448-464.CrossRef Schnittker J, Massoglia, M, Uggen C. Out and down: Incarceration and psychiatric disorder. J Health Social Beh. 2012; 53: 448-464.CrossRef
3.
Zurück zum Zitat Alexander MJ, Haugland G, Lin SP, et al. Mental health screening in addiction, corrections and social service setting: validating the MMS. Int J Ment Health Addiction. 2008; 6: 105-119.CrossRef Alexander MJ, Haugland G, Lin SP, et al. Mental health screening in addiction, corrections and social service setting: validating the MMS. Int J Ment Health Addiction. 2008; 6: 105-119.CrossRef
4.
Zurück zum Zitat Lowenkamp CT, Latessa EJ, Smith P. Does correctional program quality really matter? The impact of adhering to the principles of effective intervention 2006. Crime and Public Policy. 2006; 5: 201-220. Lowenkamp CT, Latessa EJ, Smith P. Does correctional program quality really matter? The impact of adhering to the principles of effective intervention 2006. Crime and Public Policy. 2006; 5: 201-220.
5.
Zurück zum Zitat Moggi F, Ouimette PC, Finney JW. Effectiveness of treatment of substance abuse and dependence for dual diagnosis patients: a model of treatment factors associated with one-year outcomes. J. Stud. Alcohol. 1999; 60: 856-866.PubMedCrossRef Moggi F, Ouimette PC, Finney JW. Effectiveness of treatment of substance abuse and dependence for dual diagnosis patients: a model of treatment factors associated with one-year outcomes. J. Stud. Alcohol. 1999; 60: 856-866.PubMedCrossRef
6.
Zurück zum Zitat Jones ER. Crossing the field’s quality chasm. Behav Healthc. 2006; 26: 23-24.PubMed Jones ER. Crossing the field’s quality chasm. Behav Healthc. 2006; 26: 23-24.PubMed
7.
Zurück zum Zitat Tiet QQ, Mausbach B. Treatments for patients with dual diagnosis: A review. Alcoholism: Clinical and Experimental Research. 2007; 31: 1-24.CrossRef Tiet QQ, Mausbach B. Treatments for patients with dual diagnosis: A review. Alcoholism: Clinical and Experimental Research. 2007; 31: 1-24.CrossRef
8.
Zurück zum Zitat American Psychiatric Association: Diagnostic and Statistical manual of Mental Disorders, 2013. American Psychiatric Association: Diagnostic and Statistical manual of Mental Disorders, 2013.
9.
Zurück zum Zitat Garin O, Ayuso-Mateos JL, Almansa J, et al. Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2″ in patients with chronic diseases. Health and Quality of Life Outcomes. 2010; 8: 51-58.PubMedCentralPubMedCrossRef Garin O, Ayuso-Mateos JL, Almansa J, et al. Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2″ in patients with chronic diseases. Health and Quality of Life Outcomes. 2010; 8: 51-58.PubMedCentralPubMedCrossRef
10.
11.
Zurück zum Zitat Guy W. ECDEU Assessment Manual for Psychopharmacology–Revised (DHEW Publ No ADM 76-338). NIMH Psychopharmacology Research Branch. 1976; 218–222. Guy W. ECDEU Assessment Manual for Psychopharmacology–Revised (DHEW Publ No ADM 76-338). NIMH Psychopharmacology Research Branch. 1976; 218–222.
12.
Zurück zum Zitat Tiffany ST, Friedman L, Greenfield SF, et al. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2012; 107: 709-718.PubMedCentralPubMedCrossRef Tiffany ST, Friedman L, Greenfield SF, et al. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2012; 107: 709-718.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat George P, Whelan G, Ait Khelifa N. Quality of life and disability in alcohol and drug dependent patients undergoing treatment at Depaul House. IeJSME. 2007; 1: 35-40. George P, Whelan G, Ait Khelifa N. Quality of life and disability in alcohol and drug dependent patients undergoing treatment at Depaul House. IeJSME. 2007; 1: 35-40.
14.
Zurück zum Zitat Chwastiak LA, Von Korff M. Disability in depression and back pain: Evaluation of the World Health Organization Disability Assessment Schedule (WHODAS II) in a primary care setting. J. Clinical Epidemiology. 2003; 56: 507-514.PubMedCrossRef Chwastiak LA, Von Korff M. Disability in depression and back pain: Evaluation of the World Health Organization Disability Assessment Schedule (WHODAS II) in a primary care setting. J. Clinical Epidemiology. 2003; 56: 507-514.PubMedCrossRef
15.
Zurück zum Zitat McLellan AT, McKay JR, Forman R. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005; 100: 447-458.PubMedCrossRef McLellan AT, McKay JR, Forman R. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005; 100: 447-458.PubMedCrossRef
Metadaten
Titel
The 12 Item W.H.O.D.A.S. as Primary Self Report Outcome Measure in a Correctional Community Treatment Center for Dually Diagnosed Patients
verfasst von
Leo Bastiaens
James Galus
Michael Goodlin
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 2/2015
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-014-9322-6

Weitere Artikel der Ausgabe 2/2015

Psychiatric Quarterly 2/2015 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.